Atrial Remodeling

Cocoa flavanols may reduce the risk for incident atrial fibrillation over time, perhaps as a result of atrial remodeling, according to a secondary analysis of a completed study published in European Journal of Preventative Cardiology.

The antiarrhythmic benefits of empagliflozin in patients with and without diabetes may be explained by the SGLT2 inhibitor’s ability to improve left atrial strain reservoir and contraction phase values, researchers reported.

Compared with later initiation, starting sacubitril/valsartan within 3 months of a diagnosis of HF with reduced ejection fraction was tied to better clinical outcomes and earlier left ventricular reverse remodeling, researchers reported.